US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

19.14

-0.2098-1.08%

Post-market: 19.140.00000.00%19:30 EDT

Volume:127.96K

Turnover:2.44M

Market Cap:112.91M

PE:- -

High:19.20

Open:19.04

Low:18.87

Close:19.35

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:2.99

T/O Rate:2.17%

Dividend:0.71

Dividend Rate:3.73%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Pharmaceutical Initiates Phase IB Clinical Trial of Jmt206 Injection in China

CSPC Pharma's JMT206 Injection Ib Phase Trial for Weight Management in Overweight or Obese Adults Officially Launches at First Site in China

CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval

Cspc Pharmaceutical's Recombinant Herpes Zoster Vaccine (Sys6052) Obtains FDA Clinical Trial Approval in U.S.

CSPC Pharmaceutical - Phase Ib Trial to Evaluate Jmt206 Injection as Monotherapy or with Semaglutide in Obesity

THOMSON REUTERS

CSPC Pharmaceutical - Phase Ib Clinical Trial of Jmt206 Injection for Weight Management in Adult Patients Initiated at First Study Centre in China

THOMSON REUTERS

Southbound Trading Update: Net Buy of HKD 15 Million, Increased AIA (01299) Stake by Over HKD 800 Million, Sold Off Alibaba (09988) Over HKD 500 Million

Innovent Says Trispecific Antibody Ibi3003 Posts 84.6% ORR at Phase 1 RP2D in Relapsed/refractory Multiple Myeloma

2026 Ims Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody Ibi3003 (Gprc5d/Bcma/Cd3) in Patients with Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS

China A-Share Indices Reverse Early Gains as Real Estate Stocks Surge, Vanke Hits Limit Up, Biotech Rallies, Hang Seng Tech Falls Over 1%, New Energy Vehicle Shares Decline

Hong Kong Stocks Open: Hang Seng Index Turns Lower After Flat Start; Pharma Shares Defy Trend as AKESO Surges Nearly 10%

Akeso Biotech Jumps Over 8% at Open as AstraZeneca Makes US$2 Billion Strategic Investment in Summit, Ivonescimab Gains Backing from Top Pharma

AstraZeneca's $2 Billion Stake in Summit Signals Confidence in Akeso's Ivonescimab

AstraZeneca to Invest $2 Billion in Summit Therapeutics for Cancer Drug Tie-up

US Drugmakers Turn to China for Licensing Deals

Innovent Biologics Gets China Nod for Jaypirca to Treat Chronic Lymphocytic Leukemia

MT Newswires Live

CSPC Pharma Gets China Nod for Tumor Drug Trial

MT Newswires Live

Jaypirca® (Pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (Cll) /Small Lymphocytic Lymphoma (Sll) Across All Lines of Therapy

Innovent's Jaypirca (pirtobrutinib) wins NMPA approval for all-line CLL/SLL treatment in China

Innovent Biologics - Jaypirca (Pirtrobrutinib) Approved in China for Cll/Sll Across All Lines of Therapy

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/KURE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":19.14,"timestamp":1790971200000,"preClose":19.3498,"halted":0,"volume":127957,"hourTrading":{"tag":"盘后","latestPrice":19.14,"preClose":19.14,"latestTime":"19:30 EDT","volume":8,"amount":153.12,"timestamp":1790983803066,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.010842489328054955,"floatShares":5899036,"shares":5899036,"eps":0,"marketStatus":"Market Closed","change":-0.2098,"latestTime":"10-02 16:00:00 EDT","open":19.04,"high":19.2,"low":18.87,"amount":2436278.887525,"amplitude":0.017054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":19.3498,"sharesOutstanding":4750002,"nav":19.06,"aum":112453199.16,"dividendRate":0.037315,"bidAskSpread":0.008807,"postHourTrading":{"tag":"盘后","latestPrice":19.14,"preClose":19.14,"latestTime":"19:30 EDT","volume":8,"amount":153.12,"timestamp":1790983803066,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.9854503635447447,"impliedVol":0.1722,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5899036,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.9854503635447447,"shares":5899036,"dividePrice":0.7142,"high":19.2,"amplitude":0.017054,"preClose":19.3498,"low":18.87,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":19.14,"eps":0,"divideRate":0.037315,"volume":127957,"delay":0,"ttmEps":0,"open":19.04,"prevYearClose":17.04,"prevWeekClose":18.72,"prevMonthClose":19.25,"prevQuarterClose":19.25,"fiveDayClose":18.72,"twentyDayClose":18.91,"sixtyDayClose":16.4655},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671213121","title":"CSPC Pharmaceutical Initiates Phase IB Clinical Trial of Jmt206 Injection in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2671213121","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671213121?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:21","pubTimestamp":1790677286,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharmaceutical Initiates Phase IB Clinical Trial Of JMT206 Injection In ChinaSept 29 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:PHASE IB CLINICAL TRIAL OF JMT206 INJECTION FOR WEIGH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L01V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","LU1226287529.USD","BK1521","KURE","LU1226288253.USD","IE00B543WZ88.USD","BK1191","SG9999004220.SGD","BK1515","LU0315179316.USD","01093","LU0880133367.SGD","LU1226288170.HKD","LU1807302812.USD","LU1226287875.USD","LU1960683339.HKD","LU1226287792.SGD","LU0326950275.SGD","IE0008368742.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1152091754.HKD","LU0067412154.USD","LU0072913022.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1152091168.USD","LU1951186391.HKD","LU0501845795.SGD","LU0314109678.HKD","LU1008478684.HKD","LU1328277881.USD","LU1993786604.SGD","LU1813983027.USD","IE0008369823.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195483618","title":"CSPC Pharma's JMT206 Injection Ib Phase Trial for Weight Management in Overweight or Obese Adults Officially Launches at First Site in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1195483618","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195483618?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:09","pubTimestamp":1790676579,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (01093) has announced that the Phase Ib clinical trial (JMT206–003) of its self-developed JMT206 Injection for weight management in overweight or obese adult...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287875.USD","LU2039709279.SGD","MDTX","PSYK","IE00B543WZ88.USD","BK1515","LU1226287529.USD","IBBJ","LU0501845795.SGD","IE00B031HY20.USD","LU0315179316.USD","IE00B5MMRT66.SGD","LU1008478684.HKD","LU1993786604.SGD","HK0000165453.HKD","LU1152091754.HKD","SG9999004220.SGD","LU0072913022.USD","BK1191","IE00BZ08YT58.USD","LU0067412154.USD","LU1226288170.HKD","LU1951186391.HKD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU1328277881.USD","LU0314109678.HKD","LU1807302812.USD","IE0008369823.USD","LU0880133367.SGD","LU1226288253.USD","LU1226287792.SGD","BMED","LU1813983027.USD","LU1152091168.USD","01093","LU0140636845.USD","IE0008368742.USD","BK1521","IE00BZ08YR35.GBP","LU1960683339.HKD","KURE","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154469835","title":"CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1154469835","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154469835?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:08","pubTimestamp":1790676512,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its Class 1 preventive biological product, the recombinant shingles vaccine (SYS 6052), has received approval from the US Food and Drug Administration (FDA) to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0501845795.SGD","IE00B031HY20.USD","LU1152091754.HKD","159646","IBBQ","LU1008478684.HKD","LU1226287529.USD","LU1807302812.USD","PSYK","KURE","SG9999004220.SGD","IE00BZ08YT58.USD","IBBJ","LU2039709279.SGD","LU1960683339.HKD","IE00B543WZ88.USD","LU0314109678.HKD","IE0008368742.USD","LU0315179316.USD","LU0067412154.USD","LU0880133367.SGD","LU1226287875.USD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1328277881.USD","BMED","IE00B5MMRT66.SGD","LU0140636845.USD","HK0000165453.HKD","LU1226287792.SGD","BK1515","LU1226288253.USD","01093","LU1226288170.HKD","BK1521","LU0326950275.SGD","MDTX","IE0008369823.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU1951186391.HKD","LU0072913022.USD","LU1993786604.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671133192","title":"Cspc Pharmaceutical's Recombinant Herpes Zoster Vaccine (Sys6052) Obtains FDA Clinical Trial Approval in U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2671133192","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671133192?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:07","pubTimestamp":1790676434,"startTime":"0","endTime":"0","summary":"BRIEF-Cspc Pharmaceutical's Recombinant Herpes Zoster Vaccine (Sys6052) Obtains FDA Clinical Trial Approval In U.S.Sept 29 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:PHARMA'S RECOMBINANT HERPE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0ND:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314109678.HKD","LU0315179316.USD","LU1152091754.HKD","LU1226287529.USD","LU0072913022.USD","LU1008478684.HKD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU1226287875.USD","LU1226287792.SGD","LU0326950275.SGD","IE00B031HY20.USD","LU1813983027.USD","LU1993786604.SGD","HK0000165453.HKD","SG9999004220.SGD","LU0140636845.USD","BK1191","IE00BZ08YR35.GBP","IE0008368742.USD","IE00BZ08YT58.USD","LU1226288170.HKD","KURE","IE00B5MMRT66.SGD","LU1226288253.USD","LU0880133367.SGD","LU1807302812.USD","LU0067412154.USD","01093","LU1328277881.USD","LU2039709279.SGD","BK1521","LU0501845795.SGD","LU1152091168.USD","LU1951186391.HKD","IE0008369823.USD","IE00B543WZ88.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671133372","title":"CSPC Pharmaceutical - Phase Ib Trial to Evaluate Jmt206 Injection as Monotherapy or with Semaglutide in Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671133372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671133372?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:05","pubTimestamp":1790676302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L01V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1813983027.USD","LU1226288253.USD","LU0314109678.HKD","01093","LU1328277881.USD","BK1521","IE00BZ08YT58.USD","LU1008478684.HKD","LU0067412154.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1993786604.SGD","KURE","LU0326950275.SGD","IE0008369823.USD","LU0501845795.SGD","LU1807302812.USD","LU1960683339.HKD","LU1226288170.HKD","LU1226287875.USD","IE00B031HY20.USD","LU1152091168.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU0880133367.SGD","BK1515","LU1951186391.HKD","IE00B543WZ88.USD","LU0072913022.USD","LU1152091754.HKD","LU0140636845.USD","BK1191","LU2039709279.SGD","IE0008368742.USD","HK0000165453.HKD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671133352","title":"CSPC Pharmaceutical - Phase Ib Clinical Trial of Jmt206 Injection for Weight Management in Adult Patients Initiated at First Study Centre in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2671133352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671133352?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:05","pubTimestamp":1790676302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L01V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2039709279.SGD","LU1951186391.HKD","LU0314109678.HKD","LU1226288170.HKD","BK1521","LU1226287529.USD","LU1152091168.USD","IE00B031HY20.USD","01093","IE00BZ08YR35.GBP","LU1226288253.USD","LU0067412154.USD","LU1960683339.HKD","LU1813983027.USD","BK1515","KURE","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU0315179316.USD","LU1226287792.SGD","SG9999004220.SGD","LU0072913022.USD","HK0000165453.HKD","IE0008369823.USD","BK1191","IE00BZ08YS42.EUR","LU0140636845.USD","LU1226287875.USD","LU0880133367.SGD","LU1328277881.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1807302812.USD","LU0501845795.SGD","LU1993786604.SGD","IE0008368742.USD","LU0326950275.SGD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156574558","title":"Southbound Trading Update: Net Buy of HKD 15 Million, Increased AIA (01299) Stake by Over HKD 800 Million, Sold Off Alibaba (09988) Over HKD 500 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1156574558","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156574558?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:59","pubTimestamp":1790675985,"startTime":"0","endTime":"0","summary":"On September 29 in the Hong Kong stock market, southbound trading recorded a net buy of HKD 15 million. Among this, the Shanghai Stock Connect saw a net buy of HKD 2.314 billion, while the Shenzhen...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0315179316.USD","LU0169518387.USD","00700","LU0516422366.SGD","MCHS","LU0762540952.USD","LU0878004406.USD","LU0348827113.USD","IE0032834883.USD","IE0001KFT4U8.USD","IE00B0JY6N72.USD","LU2028103732.USD","BK1149","LU1993786604.SGD","SGXZ23171101.USD","LU1316542783.SGD","02513","LU0499858438.USD","LU0502904849.HKD","LU1720051017.SGD","BK1608","LU0797268264.HKD","IE00B0169L03.USD","LU0149721374.USD","LU0499858602.USD","LU0251143458.SGD","LU1226288253.USD","LU0329678170.USD","LU0431992006.USD","LU0577902538.SGD","LU1804176565.USD","AAXJ","LU0326950275.SGD","SG9999004220.SGD","03417","LU0210533765.USD","SOCL","LU0607220059.USD","LU0882747503.HKD","LU0898667661.SGD","LU1044875133.USD","LU1831875114.USD","LU2476274720.SGD","LU0605514214.HKD","BK1095","SG9999015945.SGD","LU1880398471.USD","LU1224444064.USD","LU1188198961.HKD","LU1691799644.USD","GB00BDT5M118.USD","LU0472753341.HKD","LU0955623706.USD","SGXZ86797644.SGD","02269","LU0557290698.USD","LU0561508036.HKD","LU0784639295.USD","LU2348773727.SGD","LU2294711473.HKD","MIUmain","EMC","LU0117844026.USD","FFEM","IE0004091025.USD","LU0173614495.USD","07226","LU0029875118.USD","LU0449515922.USD","LU0577902371.SGD","BK1117","LU0823039010.USD","LU0158827781.USD","LU0540923850.HKD","LU0541502299.USD","LU3227948356.SGD","BBAX","LU0052750758.USD","LU1119993845.HKD","LU0708995153.HKD","LU1956131251.USD","LU2153591404.USD","LU1235295612.USD","02837","BK1586","LU1282651121.HKD","LU0589944569.HKD","LU1282651048.USD","LU1303224171.USD","HK0000320264.USD","LU2177674079.SGD","LU2348774022.SGD","09067","BK1193","HK0001040143.USD","LU0106959298.USD","LU3063872942.SGD","LU0762541174.USD","LU2097828557.USD","LU0197773673.USD","SG9999014674.SGD","BK1184","LU1328277881.USD","LU0054450605.USD","LU2045819591.USD","LDEM","LU2133065610.SGD","LU0509642566.USD","LU0348788117.USD","LU2257852520.SGD","LU1282648689.USD","LU0572939691.SGD","JADE","LU0700851271.USD","LU0106259558.USD","LU0128522744.USD","LU0140636845.USD","SG9999002562.SGD","LU1171460220.USD","JEMA","IE00BMPRXR70.SGD","LU0577902611.USD","IE00B8L5B284.USD","IE0034224299.USD","LU0886674414.USD","IE0003895053.USD","LU0320764243.SGD","LU0456827905.SGD","LU2152927971.USD","07552","BK1607","LU0314109678.HKD","LU0633140727.USD","HK0000914686.HKD","01299","DRGN","LU1983260115.SGD","LU1051769294.HKD","LU0011963245.USD","LU1770036033.HKD","SG9999000418.SGD","LU0823426308.USD","LU0127658192.USD","LU0048388663.USD","LU1196710864.SGD","IE00B8HQ1Z84.USD","LU0130103400.USD","LU1044876610.USD","LU0828237940.HKD","LU0096374516.USD","LU0501845795.SGD","SG9999004303.SGD","HK0001040168.HKD","XSOE","EPP","LU0791590937.USD","SG9999001846.SGD","LU0572944931.SGD","LU0348805143.USD","LU1206782309.USD","LU0868486357.SGD","LU0737861699.HKD","LU2237443549.SGD","LU1201861165.SGD","LU0054237671.USD","MIUmain","LU1064130708.USD","HSTECH","IE00BF5LJ272.USD","LU0675040207.SGD","LU0738912210.USD","688981","LU0862451753.SGD","BK1531","IE0031814852.USD","WXXWY","LU0384037296.USD","BK1588","LU2488822045.USD","LU2106854487.HKD","LU2357305700.SGD","LU0254981946.USD","SG9999001226.SGD","SG9999014021.USD","IE00BQXX3F31.USD","IE00BPRC5H50.USD","LU1974910355.USD","LU1868837722.USD","LU0821914370.USD","LU0203345920.USD","LU2111349929.HKD","LU1725190679.HKD","LU2498475776.HKD","LU0328353924.USD","LU2362541273.HKD","09988","LU0348783662.USD","TCHmain","LU1481012133.USD","LU1688375341.USD","ESPO","LU0128526141.USD","LU1734074674.USD","SGXZ62798434.SGD","LU0197773160.USD","LU0608807946.USD","LU0235996351.USD","LU0080751232.USD","IE0003795394.USD","SG9999014906.USD","IE0008369823.USD","LU0072462343.USD","LU0326948709.USD","LU0345775950.USD","LU0315178854.USD","LU0320764599.SGD","LU1328615791.USD","BK1141","LU1439103000.SGD","LU0985320562.USD","SG9999002463.SGD","BK1142","LU0158827948.USD","IE00BZ08YR35.GBP","LU0414403682.SGD","LU1712237335.SGD","LU2317271919.USD","LU0890818403.SGD","LU0130518102.USD","LU0348784397.USD","LU1718418525.SGD","IE00B3T34201.USD","SG9999000327.SGD","LU1023057109.AUD","LU0348783233.USD","BK1589","EEMX","LU1366334578.USD","LU0823038988.USD","LU1917777945.USD","LU2237443622.USD","LU0823040885.USD","SG9999001903.USD","LU0329678337.USD","LU0588545730.USD","LU0651946864.USD","LU0516423174.USD","LU1130305938.SGD","FDNI","LU0455707207.USD","SG9999000459.SGD","LU1810669033.SGD","LU2279858448.HKD","09088","BK1517","LU1048596156.SGD","LU2279701549.SGD","LU0061477393.USD","LU1655091459.SGD","IE0003851619.USD","IE0008368411.USD","LU0640798160.USD","LU0648000940.SGD","LU2148510915.USD","LU1242518857.USD","LU0143863198.USD","89988","LU1051768304.USD","LU0165289439.USD","LU2237443978.SGD","LU0228659784.USD","LU1008478684.HKD","LU0918141887.USD","LU2226246903.HKD","LU0163747925.USD","SG9999001093.SGD","IE00B29SXG58.USD","IE0008368742.USD","LU0865486749.SGD","HK0000165453.HKD","IE00B031J352.USD","LU0266013472.USD","LU2087589342.USD","LU1202635105.USD","LU0516422440.USD","HK0000288743.USD","ODDS","XIACY","LU1808992512.USD","LU0084288322.USD","LU0823413660.USD","LU1400636574.HKD","LU1807302812.USD","LU2251237306.USD","HK0000352291.HKD","LU0828238088.HKD","LU0043850808.USD","LU0577902454.USD","LU0029874061.USD","LU1733274473.HKD","BABA","LU2051468812.USD","SG9999018857.SGD","LU1048588211.SGD","SG9999015978.USD","LU0456846285.SGD","LU1282649810.SGD","LU0819123356.HKD","LU1719994722.HKD","LU0228367735.SGD","BK1614","LU0683595622.HKD","LU0210526637.USD","LU0488056044.USD","LU1515016050.SGD","KWEB","LU0192582467.USD","LU1794554557.SGD","LU1769817096.USD","IE0008368304.USD","LU0955648018.USD","LU2237443465.HKD","SG9999014914.USD","LU0541501648.USD","03088","BK1610","LU1048484197.HKD","IE00BGV7N243.SGD","LU0327786744.USD","LU1880398554.USD","LU0417516738.SGD","LU2097828631.EUR","IE0009570106.USD","SG9999002828.SGD","LU0516422952.EUR","LU0289739343.SGD","LU0588546209.SGD","LU0049853897.USD","LU1814569148.SGD","LU0359202008.SGD","LU0856984785.SGD","LU0259732245.USD","GAMR","BKF","IE00B0169N27.USD","SG9999006514.SGD","LU0672654166.SGD","LU0630378692.HKD","LU1226288170.HKD","HK0000352382.USD","LU1105468828.SGD","LU0261947096.USD","00981","LU0274383008.USD","LU0971096721.USD","LU0205439572.USD","IE00BZ08YS42.EUR","BK1523","LU0175139822.USD","LU0348816934.USD","LU1226287792.SGD","AAGIY","LU0819121731.USD","LU0979878070.USD","SG9999015986.USD","BK1618","IE00BMPRXN33.USD","BK1609","BK1502","LU0048597586.USD","LU1821325948.USD","LU1152091754.HKD","SG9999015952.SGD","HBBD.SI","LU0359201885.HKD","LU0456842615.SGD","HK0000306685.HKD","LU0417516571.SGD","LU0608807433.USD","LU0543330483.HKD","LU0543330566.HKD","LU0181495838.USD","BK1615","LU0396098781.USD","03033","LU0823426480.USD","03067","BK1506","LU0107464264.USD","SG9999007991.SGD","LU0320764755.SGD","LU0871576103.HKD","LU0831103253.SGD","LU1785774172.SGD","IE00B97KM107.HKD","LU0048575426.USD","LU0164880469.USD","BK1516","LU0516423091.SGD","HK0000914660.USD","LU2247934214.USD","LU2251237488.HKD","LU2097828805.USD","IE00B031HW06.USD","03423","LU0069063385.USD","LU0128522157.USD","LU0210527791.USD","KURE","LU1282649067.USD","LU0143863784.USD","FPA","LU0244354667.USD","LU1481107354.HKD","LU0880133367.SGD","LU0651947912.USD","LU2097828474.EUR","LU0611395673.USD","LU1224709979.USD","IE00B543WZ88.USD","HK0000320223.HKD","LU0067412154.USD","HK0000151867.HKD","LU0828237510.HKD","LU1152091168.USD","SG9999006597.SGD","SG9999014005.SGD","LU2097829019.USD","LU1226288097.SGD","LU2153592121.USD","LU0633140560.USD","LU0345776255.USD","LU0348723411.USD","LU0588545490.SGD","LU0873338254.USD","LU1064131003.USD","LU1813983027.USD","BK1170","CXSE","LU0289961442.SGD","LU1670756490.USD","LU0577902298.EUR","LU0650527681.SGD","IE0004086264.USD","IE00BYQQ9H92.USD","LU0214875030.USD","LU0051755006.USD","LU0307460666.USD","SG9999014880.SGD","01810","LU0132412106.USD","81299","BIDD","LU0823397103.USD","LU1642822792.SGD","LU0047713382.USD","LU2237443382.USD","LU1196710195.USD","LU1046422090.SGD","LU1645745479.HKD","LU1323998911.USD","LU0477156797.USD","LU2023250504.SGD","LU0231483743.USD","LU2187417386.USD","LU2265009873.SGD","LU0106252389.USD","LU1769817179.HKD","LU2023251221.USD","LU0441854154.USD","LU2449936058.SGD","LU0572940350.SGD","SGXZ51526630.SGD","LU2242644610.SGD","LU0049112450.USD","LU0737861772.HKD","LU0345769128.USD","LU0196878994.USD","LU0463099449.HKD","LU0588545904.SGD","LU0831093199.SGD","BK1249","LU0164872284.USD","LU0634319403.HKD","LU1282649141.HKD","LU1961090484.USD","LU0289960550.SGD","LU1251922891.USD","LU0593848301.USD","SG9999014039.USD","LU0359201612.USD","LU1720050803.USD","LU0211331839.USD","LU0229945570.USD","LU0261950983.USD","LU0511384066.AUD","LU1226287875.USD","BK1526","LU1951186391.HKD","EMCS","LU1226287529.USD","LU0630378429.USD","SGXZ31699556.SGD","LU0955669360.SGD","LU0057025933.USD","LU2362541513.USD","LU1211504680.USD","LU1675838814.USD","SG9999001689.USD","LU1720051108.HKD","LU0449509016.USD","BK1584","LU1196710351.USD","LU1242518931.SGD","LU0293314216.USD","LU0823041008.USD","IE00BQXX3C00.GBP","LU2362540622.SGD","LU2125910849.SGD","LU1868837565.USD","LU2476274308.USD","HK0000286598.CNH","LU2778985437.USD","LU0203347892.USD","LU0972618739.USD","LU0531971595.HKD","SG9999001051.SGD","SG9999018865.SGD","LU0188438112.USD","BK1591","LU1366334651.USD","LU1363072403.SGD","LU2293587155.HKD","IE00B031HY20.USD","LU0211977185.USD","BK1501","IE00B5MMRT66.SGD","IE00B067MR52.USD","LU0251144936.SGD","IE00B5TLWC47.USD","LU1868838027.USD","LU2089284900.SGD","LU0594300179.USD","LU0762542818.HKD","LU1880383440.USD","81810","LU2462611646.USD","LU0117841782.USD","LU0708995583.HKD","LU1733274390.USD","LU1504937902.USD","LU0348735423.USD","LU0862451837.USD","HXXD.SI","LU0918141705.HKD","LU2399975544.HKD","LU0264606111.USD","LU0072913022.USD","LU0642271901.SGD","LU0531970944.HKD","TCHI","LU1960683339.HKD","HK0000288784.HKD","601869","LU0786609619.USD","SGXZ99366536.SGD","LU1400636657.SGD","LU1623119135.USD","IE00BKZH1Z71.USD","HTCD.SI","IE00BZ08YT58.USD","LU2271345857.HKD","LU0370786039.SGD","LU0594300419.USD","SG9999017495.SGD","BK1575","LU2929501877.USD","TCEHY","06869","LU0823413587.USD","LU2125910500.SGD","LU1568876335.HKD","LU1044874839.SGD","SGXZ81514606.USD","LU1568876251.USD","LU0048580855.USD","LU0039217434.USD","03032","LU0469268626.HKD","IE00B3M56506.USD","LU1883866441.USD","SG9999014898.SGD","LU0029874905.USD","IE00BQXX3D17.EUR","LU0878005551.USD","LU1115378108.SGD","LU1400636491.USD","LU0877626530.USD","SG9999003461.SGD","01888","BK1163","LU0149534421.HKD","LU0345769631.USD","LU1439102457.SGD","LU1981816686.USD","HK0000306701.USD","LU1629966141.USD","LU2237443895.HKD","LU0164865239.USD","LU2008162690.USD","LU0287142896.SGD","SG9999001069.SGD","BK1576","LU1102505762.USD","LU1880383366.USD","LU0269904917.USD","LU0823397285.USD","LU0648948544.HKD","LU2351347302.SGD","IE0032431581.USD","BK1521","LU1102505929.USD","LU2097828714.EUR","HK0000107257.USD","LU0791591158.USD","SG9999014013.SGD","LU2089283258.USD","SGXZ90724238.SGD","LU0348825331.USD","SG9999013353.USD","LU1770034418.SGD","IE00BFXG0V08.USD","LU0261950470.USD","LU0348814723.USD","LU0070217475.USD","LU0417516902.SGD","LU1548497426.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671914282","title":"Innovent Says Trispecific Antibody Ibi3003 Posts 84.6% ORR at Phase 1 RP2D in Relapsed/refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671914282","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671914282?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:46","pubTimestamp":1790667978,"startTime":"0","endTime":"0","summary":"Innovent says trispecific antibody IBI3003 posts 84.6% ORR at Phase 1 RP2D in relapsed/refractory multiple myelomaInnovent disclosed updated Phase 1 results for IBI3003 in relapsed or refractory multi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLTnt3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0455707207.USD","BK1161","BK1583","LU2097828474.EUR","LU2097828714.EUR","01911","KURE","LU1188198961.HKD","LU1969619763.USD","LU2097828557.USD","LU0607220059.USD","LU0149534421.HKD","LU0463099449.HKD","LU2097828805.USD","LU1831875114.USD","01801","BK1589","LU2242644610.SGD","LU2097828631.EUR","LU0502904849.HKD","LU2328871848.SGD","LU2488822045.USD","LU0326950275.SGD","BK1147","LU0244354667.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671291456","title":"2026 Ims Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody Ibi3003 (Gprc5d/Bcma/Cd3) in Patients with Relapsed or Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671291456","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671291456?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:45","pubTimestamp":1790667949,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA3L9QVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU0463099449.HKD","BK1589","LU2242644610.SGD","LU2328871848.SGD","LU1831875114.USD","LU0326950275.SGD","BK1583","LU0607220059.USD","LU0244354667.USD","LU2097828474.EUR","LU2097828805.USD","LU2097828557.USD","LU2488822045.USD","HK0000165453.HKD","KURE","LU0149534421.HKD","LU2097828714.EUR","LU2097828631.EUR","LU1188198961.HKD","LU1969619763.USD","01801","LU0502904849.HKD","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183825958","title":"China A-Share Indices Reverse Early Gains as Real Estate Stocks Surge, Vanke Hits Limit Up, Biotech Rallies, Hang Seng Tech Falls Over 1%, New Energy Vehicle Shares Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1183825958","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183825958?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:34","pubTimestamp":1790649241,"startTime":"0","endTime":"0","summary":"On September 29, A-share markets traded lower in morning session, with the three major indices collectively reversing early gains after an initial rally. The micro-cap stock index rebounded, the real...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0278","07552","LU0348766576.USD","03088","BK0178","BK0157","BK0273","IE00B5MMRT66.SGD","03423","BK0180","LU1961090484.USD","LU0348827113.USD","BK4555","BK1574","03067","BK4531","BK4505","07226","LU1580142542.USD","BK4504","LU0067412154.USD","BK0183","BK1161","LU0348767384.USD","EVS.SI","LU1064130708.USD","LU0348783233.USD","LU1064131003.USD","IE00BPRC5H50.USD","03032","LU1993786604.SGD","BK4099","KURE","BK0028","LU0501845795.SGD","09866","LU0348735423.USD","IE00B543WZ88.USD","LU0708995583.HKD","000002","LU0417516902.SGD","BK4574","02202","LU0052750758.USD","LU0634319403.HKD","NIO.SI","03033","LU2399975544.HKD","LU2476274308.USD","HTImain","LU0348784397.USD","IE00B0JY6N72.USD","09926","NIOG","BK0188","LU0880133367.SGD","NIO","LU2488822045.USD","BK0196","000001","LU0320764599.SGD","LU1781817850.SGD","BK4585","BK0086","LU1720050803.USD","02837","LU1794554557.SGD","LU0417516738.SGD","BK4509","03417","LU0348825331.USD","BK0012","LU1807302812.USD","BK4526","09088","LU0072913022.USD","LU2778985437.USD","LU1328615791.USD","HSTECH","BK4548","BK4588","BK0174","LU1655091616.SGD","09067","BK0201","LU0561508036.HKD","BK4532","LU2148510915.USD","HSI","LU0540923850.HKD","LU2476274720.SGD","BK0187","BK4581","LU1226287529.USD","LU0417516571.SGD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144350622","title":"Hong Kong Stocks Open: Hang Seng Index Turns Lower After Flat Start; Pharma Shares Defy Trend as AKESO Surges Nearly 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144350622","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144350622?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:04","pubTimestamp":1790647446,"startTime":"0","endTime":"0","summary":"On September 29, Hong Kong's three major indices opened mixed before collectively turning lower.The Hang Seng Index opened up 0.02% at 24,648.64 points, and was last down 0.59% at 24,496.54 points....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["513600","LU1720050803.USD","07226","LU2399975544.HKD","03037","07500","07552","09926","LU0417516738.SGD","LU2778985437.USD","LU2488822045.USD","HTImain","LU0417516902.SGD","LU1961090484.USD","HSTECH","HHImain","IE00BPRC5H50.USD","LU1794554557.SGD","09088","07288","02802","82800","BK1161","HSI","LU0348784397.USD","07200","LU0348766576.USD","07300","02837","MCHmain","IE00B5MMRT66.SGD","03088","LU0348783233.USD","LU0634319403.HKD","02833","83115","HSImain","LU0348825331.USD","LU0540923850.HKD","82828","03416","LU2476274308.USD","03115","BK1574","LU0348767384.USD","LU0417516571.SGD","03032","07588","09115","HSCEI","09067","IE00B543WZ88.USD","KURE","LU2476274720.SGD","02828","03419","LU0348735423.USD","03033","03417","LU0561508036.HKD","02800","LU0348827113.USD","03423","03067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131412257","title":"Akeso Biotech Jumps Over 8% at Open as AstraZeneca Makes US$2 Billion Strategic Investment in Summit, Ivonescimab Gains Backing from Top Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1131412257","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131412257?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:28","pubTimestamp":1790645294,"startTime":"0","endTime":"0","summary":"Akeso Biotech (09926) opened more than 8% higher, reaching 8.37% at HK$99.7 as of press time, with a turnover of HK$56.2558 million.On the news front, Akeso Biotech's overseas partner Summit...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","IE00BPRC5H50.USD","LU2778985437.USD","VXUS","LU0348825331.USD","LU0348784397.USD","LU2476274308.USD","LU1720050803.USD","IE00B543WZ88.USD","LU1961090484.USD","BK4588","BK4585","09926","LU0348783233.USD","LU2488822045.USD","LU0348767384.USD","LU0561508036.HKD","LU2476274720.SGD","LU0348827113.USD","LU0634319403.HKD","KCAI","LU0348766576.USD","LU0417516571.SGD","LU0348735423.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU1794554557.SGD","LU2399975544.HKD","BK1161","BK1574","LU0540923850.HKD","LU0417516902.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136239524","title":"AstraZeneca's $2 Billion Stake in Summit Signals Confidence in Akeso's Ivonescimab","url":"https://stock-news.laohu8.com/highlight/detail?id=1136239524","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136239524?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:22","pubTimestamp":1790641354,"startTime":"0","endTime":"0","summary":"AstraZeneca has made a $2 billion strategic investment in Summit Therapeutics, pushing ivonescimab onto the center stage of global immuno-oncology competition. This deal not only serves as a major...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU1961090484.USD","LU2476274720.SGD","LU0417516738.SGD","LU0348827113.USD","LU0417516571.SGD","09926","IE00BPRC5H50.USD","LU0348784397.USD","LU0417516902.SGD","LU1720050803.USD","LU0348767384.USD","LU2399975544.HKD","LU0348783233.USD","BK1574","LU0634319403.HKD","IE00B543WZ88.USD","LU2778985437.USD","LU1794554557.SGD","BK1161","LU0561508036.HKD","LU2488822045.USD","LU0540923850.HKD","LU2476274308.USD","LU0348735423.USD","IE00B5MMRT66.SGD","KURE","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671638482","title":"AstraZeneca to Invest $2 Billion in Summit Therapeutics for Cancer Drug Tie-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2671638482","media":"Reuters","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671638482?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:30","pubTimestamp":1790638200,"startTime":"0","endTime":"0","summary":"AstraZeneca would invest $2 billion in Summit Therapeutics and collaborate on a ‌series of studies testing their cancer treatments together.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K1LG:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AstraZeneca to Invest $2 Billion in Summit Therapeutics for Cancer Drug Tie-up","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350171.SGD","03165","LU0348825331.USD","LU0561508036.HKD","LU2237443465.HKD","LU2399975544.HKD","LU1170363599.USD","LU0540923850.HKD","LU0310800965.SGD","LU2293690082.USD","LU2237443549.SGD","IE00BJJMRZ35.SGD","LU0827474353.SGD","LU0997586432.USD","LU1989772840.SGD","KURE","LU0211326755.USD","LU0348783233.USD","LU0957799991.USD","LU1019632923.USD","LU0171293334.USD","LU1046234339.USD","LU1078025761.USD","AZN","LU1301847155.USD","LU0889565080.SGD","SMMT","LU0211328371.USD","LU0792757196.USD","LU1104425308.USD","LU2778985437.USD","AZN.UK","IE00B5MMRT66.SGD","LU0920783379.SGD","LU0964806797.USD","BK1161","LU1989772923.USD","SG9999001176.SGD","BK5011","LU0345777659.USD","LU0011850046.USD","LU0634319403.HKD","LU1003076772.USD","LU0122379950.USD","LU0969580561.USD","LU0417516571.SGD","LU0211327993.USD","LU0553294199.USD","LU0203345920.USD","LU0949170426.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255552","title":"US Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255552","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255552?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:31","pubTimestamp":1790605880,"startTime":"0","endTime":"0","summary":"FACTBOX-US drugmakers turn to China for licensing dealsSept 28 (Reuters)-MerckMRK.Non Monday agreed to payChinese biotechSciBrunch Therapeutics $400 million upfront for global rights to an experimenta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU1868837136.USD","IE000M9KFDE8.USD","LU0316494557.USD","LU1868836757.USD","XLV","LU0053666078.USD","LU2347655073.USD","LU1941712348.USD","IE00BWXC8680.SGD","LU0058720904.USD","LU2028103732.USD","LU1732799900.SGD","LU2361044865.SGD","LU1261432733.SGD","LU2471134523.USD","LU0203201768.USD","LU0265550359.USD","IE00BVYPNV92.GBP","BK4568","LU1069347547.HKD","LU2433249047.HKD","LU0323591593.USD","LU1929549753.HKD","BMY","LU2357627491.SGD","MEDI","LU0109394709.USD","LU1988902786.USD","LU2237438978.USD","IE00BBT3K403.USD","KURE","IE00B19Z3581.USD","LLYX","LU0306807586.USD","LU2089283258.USD","FHLC","LU0912757837.SGD","LU2125154778.USD","LU2756315318.SGD","LU0607220059.USD","MHIP","LU1066051225.USD","LU0106261372.USD","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU0708995401.HKD","LU1989772840.SGD","LU0061475181.USD","LU1934455863.HKD","THNR","LU1670711123.USD","LU2362541513.USD","LU0244354667.USD","PFE","LU2236285917.USD","LU2417539215.USD","LU1670710588.SGD","LU0320765059.SGD","SGXZ81514606.USD","SG9999015945.SGD","LU1699723380.USD","SGXZ99366536.SGD","LU0417517546.SGD","LU0455707207.USD","LU1989772923.USD","LU0265550946.USD","LU0708994859.HKD","LU1064131342.USD","IE000BZT7R73.USD","LU0158827948.USD","LU0267386448.USD","LU0109391861.USD","LU2324357040.USD","PJP","LU0079474960.USD","LU1883839398.USD","LU2097828474.EUR","LU0471298694.HKD","LU0823416689.USD","IE00B3T34201.USD","LU2456880835.USD","LU1917777945.USD","IE00B4JS1V06.HKD","LU0942090050.USD","LU2213496289.HKD","LU0321505868.SGD","LU0320765646.SGD","LU2361045086.USD","LU2112291526.USD","GDOC","LU0326950275.SGD","LU0256863811.USD","LU2108987350.USD","SG9999002224.SGD","ELIS","LU0210536198.USD","LU1066053197.SGD","ELIL","LU0861579265.USD","LU1548497426.USD","LU2168564222.USD","LU1116320901.HKD","LU0122379950.USD","LU0502904849.HKD","IE0002270589.USD","SG9999002232.USD","LU0158827781.USD","IE00BFTCPJ56.SGD","REGN","LU0823434740.USD","LU1934455194.USD","SGXZ31699556.SGD","SG9999001440.SGD","LU0726765562.USD","LU2362540622.SGD","LU2552382132.HKD","LU1093756168.USD","SG9999003800.SGD","IHE","LU0170899867.USD","LU1732800096.USD","SG9999013999.USD","LLYZ","LU0345770993.USD","CURE","LU0070302665.USD","LU2097828805.USD","LU1934455277.USD","LU1868836914.USD","LU1691799644.USD","LLY","LU1366192091.USD","LU0130517989.USD","SG9999015978.USD","IE00B4R5TH58.HKD","SG9999014542.SGD","LU0096364046.USD","LU0203347892.USD","LU0432979614.USD","MRK","LU0859254822.USD","LU1035775433.USD","LU1236620834.HKD","LU0057025933.USD","LU0211331839.USD","LU0795875169.SGD","LU0882574139.USD","BK4532","LU1032466523.USD","IE00BKDWB100.SGD","LU2168563687.JPY","LU1037948541.HKD","LU2360032135.SGD","LU1551013425.SGD","LU2746668461.USD","IE000WAW04H5.SGD","SG9999015986.USD","LU0964807845.USD","LU0069063385.USD","LU1035773651.USD","LU0310799852.SGD","TRUH","LU0466842654.USD","LU2168564495.EUR","IE00BK4W5L77.USD","LU1003077747.HKD","LU0965509101.SGD","LU2462157665.USD","LU0203345920.USD","LU2125154935.USD","SG9999015341.SGD","AGNG","IE00BJJMRX11.SGD","LU2211815571.USD","IE0001KFT4U8.USD","LU0203202063.USD","IE0005OL40V9.USD","SG9999014898.SGD","LU0965508806.USD","LU2125909593.SGD","LU0225284248.USD","LU1941712264.USD","LU2491050154.USD","LU1280957306.USD","LU1983299246.USD","IE00B3PB1722.GBP","LU2746668974.SGD","IE00BVYPNW00.USD","LU2237443549.SGD","LU2491049909.HKD","IBB","LU0463099449.HKD","LU0198837287.USD","01801","LU2023250504.SGD","IE00BGHQF631.EUR","PAWZ","LU1894683348.USD","LU0097036916.USD","LU2129689605.HKD","LU2237443895.HKD","LU0820561818.USD","BK4581","LU0820562030.AUD","LU2111349929.HKD","LU1267930573.SGD","SG9999018865.SGD","IE00BJT1NW94.SGD","IE000MB6IJN5.SGD","LU2552382215.SGD","LU1244550221.USD","BK4533","IBBQ","IE00BN29S564.USD","LU0661504455.SGD","IE00BLSP4239.USD","LU2602419157.SGD","LU2242644610.SGD","LU0545039389.USD","LU0133085943.USD","LU0320765489.SGD","LU0683600562.USD","LU1037948897.HKD","LU1093756325.SGD","LU2125909247.SGD","LU0237698245.USD","LU0689472784.USD","LU0980610538.SGD","LU2237443382.USD","VHT","LU0114720955.EUR","IE0000B7K699.USD","WDNA","LU0289739343.SGD","SG9999014914.USD","LU2750360641.GBP","IE00B19Z3B42.SGD","RXL","LU2097828557.USD","IE00B1XK9C88.USD","LU1244550494.USD","LU0094547139.USD","LU1066051498.USD","LU1868837300.USD","SGXZ57979304.SGD","LU1868836591.USD","LU0006306889.USD","LU2242646821.SGD","LU2237443465.HKD","IE00B775H168.HKD","LU2750360997.AUD","IE00BFXG1179.USD","LU0238689110.USD","IE00BSNM7G36.USD","LU0648001328.SGD","BK4588","LU2461242641.AUD","LU0289739699.SGD","LU0738911758.USD","LU0965509010.AUD","IXJ","BK4592","IE0004445239.USD","LU1201861249.SGD","LU0306806265.USD","LU2168564065.EUR","GB00BDT5M118.USD","LU1074936037.SGD","BK1161","IE000F7OJYX1.SGD","LU1670628061.USD","LU0321505439.SGD","LU0130102774.USD","LU2097828714.EUR","LU0029864427.USD","LU0234570918.USD","LU2023250843.SGD","LU1831875114.USD","LU0456855351.SGD","LU2089984988.USD","LU2106854487.HKD","LU2063271972.USD","LU2471134879.HKD","LU0477156953.USD","LU2328871848.SGD","SG9999011175.SGD","LU2552382058.USD","LU0471298777.SGD","IE0004445015.USD","LU1670627923.USD","LU1670710661.SGD","LU0868494617.USD","LU2087621335.USD","LU1923622614.USD","LU1804176565.USD","LU1267930730.SGD","LU0289961442.SGD","LU0823434583.USD","LU2264538146.SGD","BK4550","IE00B42XCP33.USD","LU0353189680.USD","LU1712237335.SGD","LU2596442595.SGD","GLAM","LU1069344957.HKD","LU0320765992.SGD","LU1236620750.USD","LU0965509283.SGD","LU2271345857.HKD","HRTS","LU0354030511.USD","IE0009355771.USD","LU1291159041.SGD","LU0795875086.SGD","SG9999014567.USD","MEDX","IE00BLSP4452.SGD","LU1670711040.USD","LU0640476718.USD","LU2468319806.SGD","LU1496350502.SGD","IE00BK4W5M84.HKD","IE00BFSS7M15.SGD","SG9999001176.SGD","LU2097828631.EUR","LLII","LU2360106947.USD","BK4139","LU0949170772.SGD","LU1894683264.USD","LU2129689431.USD","SG9999017495.SGD","LU0072461881.USD","IE00B2B36J28.USD","LU1720051108.HKD","LU2237443978.SGD","SGXZ51526630.SGD","LU1839511570.USD","HK0000165453.HKD","LU0511384066.AUD","SG9999018857.SGD","SG9999014559.SGD","SG9999014880.SGD","LU0234572021.USD","SG9999015952.SGD","BK4559","PPH","LU1232071149.USD","IE00BJJMRY28.SGD","LU1323610961.USD","LU1066051811.HKD","LU0985481810.HKD","LU2471134952.CNY","LU0124676726.USD","LU1814569148.SGD","SG9999014906.USD","TMED","LU1979441026.SGD","LU0211328371.USD","LU1496350171.SGD","IE00BN8TJ469.HKD","LU2237443622.USD","LU1061106388.HKD","LU0266013472.USD","LU1551013342.USD","BMED","LU1629891620.HKD","LU1127390331.HKD","LU1162221912.USD","IYH","LU0174119429.USD","LU0553294199.USD","LU0345770308.USD","LU2168564149.EUR","LU2488822045.USD","LU2347655156.SGD","LU0256863902.USD","SG9999001176.USD","LU2462591350.SGD","LU1571399168.USD","ILDR","LU0943347566.SGD","LU0149534421.HKD","BK4599","LU2089284900.SGD","LU1057294990.SGD","LU0882574055.USD","LU2896262040.SGD","LU2087625088.SGD","LU1969619763.USD","LU0985320562.USD","TBXU","BK1583","LU2242652126.USD","BK4585","LU1430594728.SGD","IE00BKPKM429.USD","LU1585245621.USD","LU0208291251.USD","SG9999014575.USD","LU2361044949.HKD","LU1023059063.AUD","IE00BFSS8Q28.SGD","IE00BJLML261.HKD","ABBV","LU0889565916.HKD","BK4534","BBH","BK1589","LU1116320737.USD","LU2491050071.SGD","LU0098860793.USD","LU1188198961.HKD","LU0385154629.USD","LU2023251221.USD","LU1244550577.SGD","IE00B1BXHZ80.USD","LU1974910355.USD","LU2265009873.SGD","LU0395794307.EUR","LU2756315664.SGD","LU2129689514.USD","LU2357305700.SGD","LU0689626769.HKD","LU2471134796.USD","LU1145028129.USD","LU1989771016.USD","LU0225283273.USD","LU0472753341.HKD","IE000SO60NU8.SGD","LU0128525929.USD","IE00B7KXQ091.USD","LU0868494708.USD","SG9999015358.SGD","LU1718418525.SGD","LU0672654240.SGD","BK4516","LU2023250330.USD","LU2362541273.HKD","LU1623119135.USD","BK4566","LU0787776722.HKD","LU0786609619.USD","CANC","LU0211327993.USD","BK4007","IE00BDGV0183.EUR","IE0002141913.USD","LU0225771236.USD","LU2133065610.SGD","LU1267930490.SGD","LU1720051017.SGD","LU0354030438.USD","JDOC","LU0820561909.HKD","OZEM","FTXH","LU0353189763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670625231","title":"Innovent Biologics Gets China Nod for Jaypirca to Treat Chronic Lymphocytic Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2670625231","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670625231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:15","pubTimestamp":1790594155,"startTime":"0","endTime":"0","summary":"Innovent Biologics (HKG:1801) obtained approval for Jaypirca from China's National Medical Products Administration, a Monday bourse filing showed.The approval is for the drug as monotherapy to treat adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2488822045.USD","HK0000165453.HKD","KURE","BK1583","LU0149534421.HKD","LU2097828714.EUR","LU1831875114.USD","BK1161","LU0607220059.USD","LU2097828805.USD","01801","LU2242644610.SGD","LU2097828557.USD","LU0502904849.HKD","LU2328871848.SGD","LU0326950275.SGD","LU0463099449.HKD","LU0244354667.USD","BK1589","LU1969619763.USD","LU0455707207.USD","LU2097828631.EUR","LU1188198961.HKD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670923186","title":"CSPC Pharma Gets China Nod for Tumor Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2670923186","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670923186?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:04","pubTimestamp":1790593465,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) obtained clinical trial approval for SYS6077 injection from China's National Medical Products Administration.The indication for the approval is for advanced malignant tumors, a Monday Hong Kong bourse filing showed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0880133367.SGD","BK1191","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1226287792.SGD","LU1951186391.HKD","LU1993786604.SGD","LU0140636845.USD","LU1328277881.USD","LU1226287875.USD","IE00BZ08YR35.GBP","LU0315179316.USD","SG9999004220.SGD","LU1960683339.HKD","LU1807302812.USD","LU1813983027.USD","IE0008368742.USD","IE00B543WZ88.USD","KURE","LU0072913022.USD","LU1226287529.USD","BK1515","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1152091168.USD","LU0067412154.USD","01093","IE00BZ08YT58.USD","LU1008478684.HKD","LU0314109678.HKD","HK0000165453.HKD","LU2039709279.SGD","LU1226288253.USD","BK1521","LU1152091754.HKD","IE0008369823.USD","IE00B031HY20.USD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239864","title":"Jaypirca® (Pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (Cll) /Small Lymphocytic Lymphoma (Sll) Across All Lines of Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239864","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239864?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:39","pubTimestamp":1790591992,"startTime":"0","endTime":"0","summary":"BRIEF-Jaypirca (Pirtobrutinib) Approved In China For A New Indication In Chronic Lymphocytic Leukemia (Cll) /Small Lymphocytic Lymphoma (Sll) Across All Lines Of TherapySept 28 (Reuters)-Innovent Biol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA2WRDHQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0502904849.HKD","LU2097828557.USD","LU2488822045.USD","LU0455707207.USD","LU2097828631.EUR","BK1583","LU2097828714.EUR","LU2097828805.USD","LU2328871848.SGD","KURE","LU0463099449.HKD","HK0000165453.HKD","LU1188198961.HKD","BK1161","LU2097828474.EUR","LU0607220059.USD","01801","LU0244354667.USD","LU1969619763.USD","LU1831875114.USD","LU0149534421.HKD","LU0326950275.SGD","BK1589","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174068672","title":"Innovent's Jaypirca (pirtobrutinib) wins NMPA approval for all-line CLL/SLL treatment in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1174068672","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174068672?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:18","pubTimestamp":1790590702,"startTime":"0","endTime":"0","summary":"Innovent Biologics (01801) has announced that its marketed non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor Jaypirca (pirtobrutinib) has officially received approval from China's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1831875114.USD","LU0502904849.HKD","LU2097828714.EUR","LU2488822045.USD","LU1969619763.USD","LU2242644610.SGD","LU2097828805.USD","BK1161","KURE","LU2328871848.SGD","LU0455707207.USD","LU2097828474.EUR","LU2097828557.USD","LU0326950275.SGD","LU0607220059.USD","01801","LU0463099449.HKD","LU0149534421.HKD","BK1583","HK0000165453.HKD","LU2097828631.EUR","LU1188198961.HKD","BK1589","LU0244354667.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236395","title":"Innovent Biologics - Jaypirca (Pirtrobrutinib) Approved in China for Cll/Sll Across All Lines of Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236395","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236395?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:11","pubTimestamp":1790590260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I0DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2328871848.SGD","LU0502904849.HKD","LU2242644610.SGD","BK1161","BK1589","LU0463099449.HKD","LU0149534421.HKD","LU2097828714.EUR","LU2097828631.EUR","LU2097828557.USD","LU1831875114.USD","LU0607220059.USD","LU0326950275.SGD","LU2097828474.EUR","HK0000165453.HKD","LU0455707207.USD","LU1188198961.HKD","LU2488822045.USD","KURE","LU1969619763.USD","01801","BK1583","LU2097828805.USD","LU0244354667.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}